metyrapone has been researched along with Hyperlipidemias in 6 studies
Metyrapone: An inhibitor of the enzyme STEROID 11-BETA-MONOOXYGENASE. It is used as a test of the feedback hypothalamic-pituitary mechanism in the diagnosis of CUSHING SYNDROME.
metyrapone : An aromatic ketone that is 3,3-dimethylbutan-2-one in which the methyl groups at positions 1 and 4 are replaced by pyridin-3-yl groups. A steroid 11beta-monooxygenase (EC 1.14.15.4) inhibitor, it is used in the diagnosis of adrenal insufficiency.
Hyperlipidemias: Conditions with excess LIPIDS in the blood.
Excerpt | Relevance | Reference |
---|---|---|
"BLA = bilateral adrenalectomy CD = Cushing disease CS = Cushing syndrome eCRF = electronic case report form MRI = magnetic resonance imaging PCOS = polycystic ovary syndrome." | 1.46 | BIOCHEMICAL CONTROL DURING LONG-TERM FOLLOW-UP OF 230 ADULT PATIENTS WITH CUSHING DISEASE: A MULTICENTER RETROSPECTIVE STUDY. ( Ayala, A; Biller, BMK; Bonert, V; Broder, MS; Carmichael, JD; Cherepanov, D; Eagan, M; Geer, EB; Gordon, MB; Hannoush, Z; Katznelson, L; Lalazar, Y; Lee, J; Manuylova, E; Neary, MP; Pulaski-Liebert, KJ; Said, Q; Shafiq, I; Surampudi, V; Swerdloff, RS, 2017) |
"Imaging tests by CT/MRI identified the tumors in 8 of 16 (50%), in 4 of 11 (36%) and 4 of 6 (66." | 1.36 | Clinical features and management of ectopic ACTH syndrome at a single institute in Japan. ( Doi, M; Hirata, Y; Izumiyama, H; Sugiyama, T; Yoshimoto, T, 2010) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (66.67) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Geer, EB | 1 |
Shafiq, I | 1 |
Gordon, MB | 1 |
Bonert, V | 1 |
Ayala, A | 1 |
Swerdloff, RS | 1 |
Katznelson, L | 1 |
Lalazar, Y | 1 |
Manuylova, E | 1 |
Pulaski-Liebert, KJ | 1 |
Carmichael, JD | 1 |
Hannoush, Z | 1 |
Surampudi, V | 1 |
Broder, MS | 1 |
Cherepanov, D | 1 |
Eagan, M | 1 |
Lee, J | 1 |
Said, Q | 1 |
Neary, MP | 1 |
Biller, BMK | 1 |
Doi, M | 1 |
Sugiyama, T | 1 |
Izumiyama, H | 1 |
Yoshimoto, T | 1 |
Hirata, Y | 1 |
RUVALCABA, RH | 2 |
KELLEY, VC | 2 |
Gorbachev, VV | 1 |
Livshits, IB | 1 |
Sareen, CK | 1 |
Dingman, JF | 1 |
6 other studies available for metyrapone and Hyperlipidemias
Article | Year |
---|---|
BIOCHEMICAL CONTROL DURING LONG-TERM FOLLOW-UP OF 230 ADULT PATIENTS WITH CUSHING DISEASE: A MULTICENTER RETROSPECTIVE STUDY.
Topics: 14-alpha Demethylase Inhibitors; ACTH-Secreting Pituitary Adenoma; Adenoma; Adolescent; Adrenalectom | 2017 |
Clinical features and management of ectopic ACTH syndrome at a single institute in Japan.
Topics: ACTH Syndrome, Ectopic; Adrenocorticotropic Hormone; Adult; Aged; Corticotropin-Releasing Hormone; D | 2010 |
LIPOATROPHIC DIABETES. II. METABOLIC STUDIES CONCERNING THE MECHANISM OF LIPEMIA.
Topics: Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Cholesterol; Diabetes Mellitus, Lipoatrophic; | 1965 |
[Somatotropic function of the hypophysis in arteriosclerosis].
Topics: Adult; Aged; Animals; Coronary Disease; Female; Glucose Tolerance Test; Growth Hormone; Humans; Hype | 1976 |
Partial hypopituitarism, hypoglycemia, and hyperlipemia in Albright's dystrophy.
Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adult; Disorders of Sex Development; Female; Glucose Tol | 1974 |
Treatment of familial hypercholesterolemia with metyrapone.
Topics: Adult; Cholesterol; Female; Humans; Hyperlipidemias; Metyrapone; Middle Aged | 1972 |